Pfizer reported up to 12.3% placebo-adjusted weight loss at 28 weeks in a phase 2b trial of PF-08653944 (formerly MET-097i), a GLP-1 receptor agonist acquired through its $10 billion Metsera deal. In the Vesper-3 trial (~250 adults with obesity or overweight without diabetes), patients transitioned…
FUJIFILM Healthcare Europe has announced that its latest 800-series duodenoscopes are now compatible with a newly CE-mark–approved sterilization cycle —…
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening…
From seismic policy shifts to blockbuster deals and the accelerating migration of higher-acuity care into the outpatient setting, 2025 was…
Earlier this year the Centers for Medicare and Medicaid Services introduced the “Wasteful and Inappropriate Service Reduction” model, a series…
DDW 2025
A new DDW 2025 study reveals a surprising truth: most post-polypectomy colorectal…
With 19 million more patients now eligible for colorectal cancer screening, the…
Headlines in GI
UMass’ Division of Gastroenterology has completed its first Full-Thickness Resection Device (FTRD)…
As artificial intelligence tools become embedded in clinical workflows — from imaging…
Thought Leadership
A new editorial in the ACG Case Reports Journal argues that nutrition and lifestyle medicine must move from peripheral topics to core competencies in…
The story of gastroenterology in 2025 is no longer about productivity or…
Gastroenterology is facing a growing anesthesia staffing mismatch—driven not just by workforce…
In a surprisingly funny and philosophical essay, The New York Times writer…
ARTIFICIAL INTELLIGENCE (AI)
San Francisco-based startup Oath Surgical has partnered with NVIDIA to embed real-time AI analytics into its outpatient surgery center operating…
Tech & Innovation
Business
San Francisco-based startup Oath Surgical has partnered with NVIDIA to embed real-time…
Leadership
Here are five gastroenterology and GI surgery physician additions recently reported by…